首页> 中文期刊> 《医药前沿 》 >清创性肝切除联合选择性入肝血流阻断治疗严重肝外伤的临床研究

清创性肝切除联合选择性入肝血流阻断治疗严重肝外伤的临床研究

         

摘要

目的:探讨清创性肝切除联合选择性入肝血流阻断治疗严重肝外伤的临床效果。方法:选取本院2011年2月—2013年2月诊治的严重肝外伤患者53例为观察组,行清创性肝切除联合选择性入肝血流阻断治疗。选取本院2008年2月—2011年1月诊治的严重肝外伤患者57例为对照组,行清创性肝切除治疗。比较两组患者的手术指征、预后情况、并发症情况。结果:观察组患者手术时间明显长于对照组,观察组患者术中出血量、术后住院时间均明显小于对照组,观察组患者治愈率明显高于对照组,观察组患者并发症发生率明显低于对照组,差异均有统计学意义(p<0.05)。结论:清创性肝切除联合选择性入肝血流阻断是治疗严重肝外伤的有效方法,对患者造成的创伤较小,可明显提高患者的治愈率,并发症少且安全性高,值得临床推广使用。%Objective Discuss joint debridement sex liver resection selective into hepatic blood flow blocking the clinical effect of treatment of severe liver trauma.Methods Selected in our hospital from February 2011 to February 2013 diagnosis and treatment of severe liver trauma patients and 53 cases of observation group, joint debridement sex liver resection selective hepatic blood flow blocking treatment.Results Observation group of patients with operation time is longer than the control group and observation group of patients, intraoperative blood loss, postoperative hospital stay were significantly less than the control group and observation group of patients cure rate is significantly higher than the control group, the complication rate of observation group of patients significantly lower than the control group, the differences were statistically significant (p<0.05).Conclusions Debridement sex joint selective hepatic blood flow blocking, liver resection for patients with less trauma, can obviously improve the cure rate of patients, fewer complications and high safety, worth clinical promotion use.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号